• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚山梨酯 20 降解导致游离脂肪酸颗粒形成的硅酮油的影响。

Impact of Silicone Oil on Free Fatty Acid Particle Formation due to Polysorbate 20 Degradation.

机构信息

Purification Development, Genentech Inc, 1 DNA Way, South San Francisco, California, 94080, USA.

Pharmaceutical Development, Genentech Inc., 1 DNA Way, South San Francisco, California, 94080, USA.

出版信息

Pharm Res. 2020 Oct 7;37(11):216. doi: 10.1007/s11095-020-02936-3.

DOI:10.1007/s11095-020-02936-3
PMID:33029664
Abstract

PURPOSE

Polysorbate 20 (PS20), a commonly used surfactant in biopharmaceutical formulations, can undergo hydrolytic degradation resulting in free fatty acids (FFAs) that precipitate to form particles. This work investigates the ability for silicone oil (si-oil) coated on the interior walls of prefilled syringes (PFSs) to act as a sink for FFAs and potentially delay FFA particle formation.

METHODS

Myristic acid distribution coefficient was measured in a two-phase system containing si-oil and formulation buffer at a range of aqueous conditions. An empirical model was built from these data to predict distribution coefficient based on aqueous conditions. To verify the model, PS20 was degraded using model lipases side-by-side in glass vials and PFSs while monitoring sub-visible particles.

RESULTS

The empirical model demonstrates that the partitioning of myristic acid into si-oil is maximized at low pH and low PS20 concentration. The model predicts that the presence of si-oil at levels typical in PFSs provides at most an 8.5% increase in the total carrying capacity for myristic acid compared to a non-coated glass vial. The time to onset of FFA particles was equivalent between degradations performed in two PFS models coated with differing levels of silicone oil and in non-coated glass vials.

CONCLUSION

Herein, we demonstrate that FFAs partition from aqueous solution into si-oil. However, the extent of the partitioning effect is not large enough to delay PS20-related FFA particle formation at typical formulation conditions (pH 5.0-7.5, 0.01% - 0.1% w/v PS20) filled in typical PFSs (<1.0 mg si-oil/mL aqueous fill).

摘要

目的

聚山梨酯 20(PS20)是生物制药制剂中常用的表面活性剂,可发生水解降解,生成游离脂肪酸(FFA)并沉淀形成颗粒。本研究考察了硅油(si-oil)涂覆于预充式注射器(PFS)内壁的能力,即作为 FFA 的收容所,并可能延迟 FFA 颗粒形成。

方法

在包含 si-oil 和制剂缓冲液的两相体系中,测量豆蔻酸分配系数,考察在一系列水相条件下的分配系数。根据这些数据建立经验模型,基于水相条件预测分配系数。为了验证模型,采用模型脂肪酶在玻璃小瓶和 PFS 中同时降解 PS20,同时监测亚可见颗粒。

结果

经验模型表明,在低 pH 和低 PS20 浓度下,豆蔻酸分配到 si-oil 中的分配系数最大。该模型预测,与非涂覆玻璃小瓶相比,在 PFS 中典型水平下存在 si-oil 最多可使豆蔻酸的总承载能力增加 8.5%。在两种涂覆不同水平硅油的 PFS 模型和非涂覆玻璃小瓶中进行的降解实验中,FFA 颗粒出现的时间相同。

结论

本研究表明,FFA 从水相分配到 si-oil 中。然而,分配效应的程度不足以在典型制剂条件(pH 5.0-7.5,0.01%-0.1%w/v PS20)下延迟 PS20 相关 FFA 颗粒形成,典型 PFS 中的填充量(<1.0mg si-oil/mL 水填充量)。

相似文献

1
Impact of Silicone Oil on Free Fatty Acid Particle Formation due to Polysorbate 20 Degradation.聚山梨酯 20 降解导致游离脂肪酸颗粒形成的硅酮油的影响。
Pharm Res. 2020 Oct 7;37(11):216. doi: 10.1007/s11095-020-02936-3.
2
Improving Prediction of Free Fatty Acid Particle Formation in Biopharmaceutical Drug Products: Incorporating Ester Distribution during Polysorbate 20 Degradation.提高生物制药制剂中游离脂肪酸粒子形成预测的准确性:在聚山梨酯 20 降解过程中考虑酯分布。
Mol Pharm. 2020 Nov 2;17(11):4354-4363. doi: 10.1021/acs.molpharmaceut.0c00794. Epub 2020 Oct 8.
3
Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.生物治疗性预填充注射器中亚可见颗粒的特征:在滴震后硅油和蛋白质亚可见颗粒的形成中,聚山梨酯和蛋白质的作用。
J Pharm Sci. 2020 Jan;109(1):640-645. doi: 10.1016/j.xphs.2019.10.066. Epub 2019 Nov 2.
4
Understanding Particle Formation: Solubility of Free Fatty Acids as Polysorbate 20 Degradation Byproducts in Therapeutic Monoclonal Antibody Formulations.理解颗粒形成:游离脂肪酸作为聚山梨酯20降解副产物在治疗性单克隆抗体制剂中的溶解度
Mol Pharm. 2015 Nov 2;12(11):3792-804. doi: 10.1021/acs.molpharmaceut.5b00310. Epub 2015 Oct 13.
5
Evaluating a Modified High Purity Polysorbate 20 Designed to Reduce the Risk of Free Fatty Acid Particle Formation.评估一种改良的高纯度聚山梨酯 20,旨在降低游离脂肪酸颗粒形成的风险。
Pharm Res. 2021 Sep;38(9):1563-1583. doi: 10.1007/s11095-021-03087-9. Epub 2021 Sep 8.
6
Stress-mediated polysorbate 20 degradation and its potential impact on therapeutic proteins.应激介导的聚山梨酯 20 降解及其对治疗性蛋白的潜在影响。
Pharm Res. 2024 Jun;41(6):1217-1232. doi: 10.1007/s11095-024-03700-7. Epub 2024 May 13.
7
Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw material.蛋白质制剂中的游离脂肪酸颗粒,第2部分:聚山梨酯原料的作用。
J Pharm Sci. 2015 Feb;104(2):447-56. doi: 10.1002/jps.24144. Epub 2014 Sep 5.
8
Particle Characterization for a Protein Drug Product Stored in Pre-Filled Syringes Using Micro-Flow Imaging, Archimedes, and Quartz Crystal Microbalance with Dissipation.使用微流成像、阿基米德法和带耗散的石英晶体微天平对预填充注射器中储存的蛋白质药物产品进行颗粒表征。
AAPS J. 2017 Jan;19(1):110-116. doi: 10.1208/s12248-016-9983-1. Epub 2016 Sep 12.
9
Glass Leachables as a Nucleation Factor for Free Fatty Acid Particle Formation in Biopharmaceutical Formulations.玻璃浸出物作为生物制药制剂中游离脂肪酸颗粒形成的成核因子。
J Pharm Sci. 2021 Feb;110(2):785-795. doi: 10.1016/j.xphs.2020.09.050. Epub 2020 Oct 7.
10
Dissolution of Polysorbate 20 Degradation Related Free Fatty Acid Particles in Intravenous Bag Solutions.聚山梨酯 20 降解相关游离脂肪酸颗粒在静脉输液袋溶液中的溶解情况。
J Pharm Sci. 2021 Feb;110(2):687-692. doi: 10.1016/j.xphs.2020.10.004. Epub 2020 Oct 8.

引用本文的文献

1
Small-angle x-ray scattering investigation of the integration of free fatty acids in polysorbate 20 micelles.小角 X 射线散射研究游离脂肪酸在聚山梨酯 20 胶束中的整合。
Biophys J. 2023 Aug 8;122(15):3078-3088. doi: 10.1016/j.bpj.2023.06.011. Epub 2023 Jun 19.